Barnett & Company, Inc. Gilead Sciences, Inc. Transaction History

Barnett & Company, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 28, 2022	SELL	$57.92 - $72.58 $14,480 - $18,145	-250 Closed	0 $0
Q2 2020 Jul 22, 2020	SELL	$72.34 - $84.0 $42,391 - $49,224	-586 Reduced 70.1%	250 $19,000
Q1 2020 Apr 23, 2020	BUY	$62.63 - $80.22 $31,315 - $40,110	500 Added 148.81%	836 $62,000
Q4 2019 Jan 22, 2020	BUY	$61.62 - $67.78 $5,299 - $5,829	86 Added 34.4%	336 $22,000
Q3 2017 Nov 20, 2017	BUY	$72.11 - $85.47 $18,027 - $21,367	250	250 $20,000

1,926

992M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $118B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Barnett & Company, Inc., based on Form 13F filings with the SEC.

Stay updated on Barnett & Company, Inc. with notifications on news.